CHADS-P2A2RC 评分则有 24.9% 患者属于高危(≥ 4 分)、48.1% 为中危(2～3 分)、27.0% 为低危(≤ 1 分)。 每100 人年的主要不良心血管事件,两种方案均被认为是高危的患者为 4.8;ESC 标准高危但 CHADS-P2A2RC 低中危的患者为 2.1;ESC 标准低中危而 CHADS-P2A2RC 评分为高危的患者为 3.8;两种标准...
Comparison of CHADS2 score with CHADSVASC-Score in a prospective multicenter registry on patients with atrial fibrillation undergoing coronary artery stenting (AFCAS-trial)A., SchlittA., RubboliJ., ValenciaP., KarjalainenM., WeberM., Puurunen...
CHADS2 score (HR 1.46; CI 1.36 to 1.56, p<0.001) and CHA2DS2-VASc score (HR 1.39; CI 1.31 to 1.46, p<0.001) were associated with mortality. Results were still significant after adjusting for AF and anticoagulation therapy. Conclusions CHADS2 and CHA2DS2-VASc score are associated with ...
AIMS: The (2)DS(2)-VASc score is a modification of the CHADS(2) score that aims to improve risk prediction in patients with (AF) by adding three risk factors: age 65-74, female sex, and history of . Whereas previous evaluations of the (2)DS(2)-VASc score included all AF patients...
与CHADS2评分相比,CHA2DS2-VASc评分有两项重要的变化,一是细化了年龄分层,将年龄超过75岁的权重增加为2分,年龄65～75岁仍为1分;二是新增了两个危险因素:女性和血管性疾病,均为1分。CHA2DS2-VASc评分系统是欧洲基于整体的高抗凝率而进一步做了细分,当时的欧洲除极少数国家抗凝率不理想外,不少国家抗凝率已经高达...
CHADS2和CHA2DS2-VASc评分对非心房颤动心脏疾病患者卒中的预测价值要点 万方数据
Recent reports have shown that CHADS2 score can be applied to stroke risk in coronary artery disease (CAD) patients. This study evaluated the efficacy of CHADS2, CHA2DS2-VASc and R2CHADS2 scores as prognostic tools for stroke subsequent to CAD.We enrolled 159 consecutive patients with acute ...
The risk of stroke in patients with atrial fibrillation (AF) can be assessed by use of the CHADS2and the CHA2DS2-VASc score system. We hypothesised that th... JH Svendsen,JC Nielsen,S Darkner,... - 《Heart》 被引量: 56发表: 2013年 Meta-analysis of CHADS2 versus CHA2DS2-VASc...
curve受试者工作特性曲线TIATransient ischemic attack短暂性脑缺血发作OROdds ratio比值比1比较 CHADS2、CHA2DS2-VASc、R2-CHADS2 三种评分对非瓣膜性房颤患者卒中风险分层作用摘要目的:研究 CHADS2、CHA2DS2-VASc、R2-CHADS2 三种评分对 我国非瓣膜性房颤患者卒中的风险分层作用,为我国非瓣膜性房颤患 者临床口服...
【摘要】CHADS2 和 CHA2DS2-VASc 评分是非瓣膜性心房颤动患者卒中风险分 层和指导抗凝治疗的常用工具.最近研究发现上述评分亦可用于预测非心房颤动患 者卒中、不良心血管事件和死亡风险以及临床预后.现就 CHADS2 和 CHA2DS 2VASe 评分相关的临床最新应用做一综述.%CHADS2 and CHA2DS2-VASc score are widely ...